Targeting apoptotic and autophagic pathways for cancer therapeutics
Authors:
- Bo LiuBLBo Liu
- Jin-Ku BaoJBJin-Ku Bao
- 1 January 2011
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 300 (2) , 105-114
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Autophagic pathways as new targets for cancer drug developmentActa Pharmacologica Sinica, 2010
- Crosstalk between apoptosis and autophagy within the Beclin 1 interactomeThe EMBO Journal, 2010
- Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondriaCell Death & Disease, 2010
- Autophagy and tumorigenesisFEBS Letters, 2009
- Role and regulation of autophagy in cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- p53: The Janus of autophagy?Nature Cell Biology, 2008
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerationsDrug Resistance Updates, 2008
- Apoptosis and autophagy: regulatory connections between two supposedly different processesApoptosis, 2007
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisCancer Cell, 2006
- The Hallmarks of CancerCell, 2000